The Smarter Way To Bet On Anthropic And OpenAI

Key Takeaways

• VCX trades at ~15 times its net asset value
• Overpaying reduces potential returns for AI exposure
• Direct Anthropic stakes offer better risk‑adjusted upside
• OpenAI access possible via private rounds or related ETFs
• Diversified AI funds provide balanced exposure without premium

Summary

Investors are flocking to VCX, the Fundrise Growth Tech Fund, paying roughly 15 times its net asset value solely for exposure to Anthropic. The author argues that this premium is unjustified given the availability of superior, lower‑cost avenues to invest in both Anthropic and OpenAI. By overpaying, shareholders risk diluting returns while ignoring more efficient market options. The post urges a disciplined approach to AI‑focused investing rather than chasing hype.

Pulse Analysis

The AI boom has turned a handful of companies into investment magnets, and Anthropic is no exception. VCX, a publicly traded fund that holds Anthropic shares, has surged to a valuation roughly fifteen times its net asset value, a premium driven more by hype than fundamentals. Such a steep multiple compresses future earnings potential and leaves investors vulnerable if the AI market cools or if Anthropic’s growth stalls. In a landscape where capital is abundant, paying a hefty premium for a single‑company exposure is increasingly hard to justify.

Savvy investors have a menu of alternatives that deliver comparable or superior exposure at a fraction of the cost. Direct secondary market purchases of Anthropic equity, participation in private placement rounds, or allocation to venture‑focused ETFs that include both Anthropic and OpenAI provide diversified risk and lower entry prices. Funds such as the Global X AI & Technology ETF or the ARK Innovation ETF already hold stakes in leading AI firms, offering balanced exposure without the inflated premium seen in VCX. Moreover, secondary markets for private AI stocks have matured, allowing accredited investors to acquire shares at market‑driven prices rather than inflated fund premiums.

Strategically, the key is to align AI exposure with valuation discipline and portfolio diversification goals. Overpaying for a single‑company vehicle can skew risk‑return profiles, especially in a sector prone to rapid valuation swings. By leveraging diversified AI funds, direct equity opportunities, or structured private placements, investors can capture the upside of Anthropic and OpenAI while preserving capital efficiency. This measured approach not only safeguards against hype‑driven price distortions but also positions portfolios to benefit from the long‑term growth trajectory of artificial intelligence technologies.